These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
105 related items for PubMed ID: 3532667
21. Study of A- and B-cell function in beta-thalassemia major. Maioli M, Pacifico A, Frulio T, Longinotti M. Acta Diabetol Lat; 1983; 20(2):143-52. PubMed ID: 6349202 [Abstract] [Full Text] [Related]
22. [Influence of total pancreatectomy on the secretion of human growth hormone and the endocrine pancreas]. Takaesu Y, Nimura Y, Hayakawa N, Yasui K, Ohtsuka K. Nihon Geka Gakkai Zasshi; 1988 Oct; 89(10):1686-91. PubMed ID: 3059167 [Abstract] [Full Text] [Related]
23. Insulin sensitivity and B-cell responsiveness to glucose during late pregnancy in lean and moderately obese women with normal glucose tolerance or mild gestational diabetes. Buchanan TA, Metzger BE, Freinkel N, Bergman RN. Am J Obstet Gynecol; 1990 Apr; 162(4):1008-14. PubMed ID: 2183610 [Abstract] [Full Text] [Related]
24. Correlation between minimal secretory capacity of pancreatic beta-cells and stability of diabetic control. Fukuda M, Tanaka A, Tahara Y, Ikegami H, Yamamoto Y, Kumahara Y, Shima K. Diabetes; 1988 Jan; 37(1):81-8. PubMed ID: 3275557 [Abstract] [Full Text] [Related]
25. The mechanism of exaggerated glucagon response to arginine in diabetes mellitus. Kawamori R, Shichiri M, Kikuchi M, Yamasaki Y, Abe H. Diabetes Res Clin Pract; 1985 Oct; 1(3):131-7. PubMed ID: 3915260 [Abstract] [Full Text] [Related]
26. Evaluation of B-cell secretion and peripheral insulin resistance during pregnancy and after delivery in gestational diabetes mellitus with obesity. Botta RM, Sinagra D, Donatelli M, Amato MP, Angelico MC, Cangemi C, Bompiani G. Acta Diabetol Lat; 1988 Oct; 25(1):81-8. PubMed ID: 3043990 [Abstract] [Full Text] [Related]
27. Impaired beta-cell function, incretin effect, and glucagon suppression in patients with type 1 diabetes who have normal fasting glucose. Greenbaum CJ, Prigeon RL, D'Alessio DA. Diabetes; 2002 Apr; 51(4):951-7. PubMed ID: 11916912 [Abstract] [Full Text] [Related]
28. Insulin secretory capacity and the regulation of glucagon secretion in diabetic and non-diabetic alcoholic cirrhotic patients. Kruszynska YT, Goulas S, Wollen N, McIntyre N. J Hepatol; 1998 Feb; 28(2):280-91. PubMed ID: 9514541 [Abstract] [Full Text] [Related]
29. Serum free C-peptide response to oral glucose loading as a parameter for the monitoring of pancreatic B-cell function in diabetic patients. Hsieh SD, Kanazawa Y, Akanuma Y. Diabetes Res Clin Pract; 1985 Aug; 1(2):109-14. PubMed ID: 3915258 [Abstract] [Full Text] [Related]
30. Examining the effects of hyperglycemia on pancreatic endocrine function in humans: evidence for in vivo glucotoxicity. Solomon TP, Knudsen SH, Karstoft K, Winding K, Holst JJ, Pedersen BK. J Clin Endocrinol Metab; 2012 Dec; 97(12):4682-91. PubMed ID: 23043193 [Abstract] [Full Text] [Related]
31. Hormonal, metabolic, and circulatory responses to insulin-induced hypoglycemia in pregnant and nonpregnant women with insulin-dependent diabetes. Nisell H, Persson B, Hanson U, Lunell NO, Nylund L, Sarby B, Thronström S. Am J Perinatol; 1994 May; 11(3):231-6. PubMed ID: 8048992 [Abstract] [Full Text] [Related]
32. Failure of indomethacin to affect arginine-induced C-peptide and glucagon release in insulin-treated diabetics. Major role of residual B cell function in conditioning the magnitude of the blood glucose rise after intravenous arginine. Luyckx AS, Mendoza E, Lefebvre PJ. Diabetologia; 1981 Oct; 21(4):376-82. PubMed ID: 7026333 [Abstract] [Full Text] [Related]
33. The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotype. Vilsbøll T, Knop FK, Krarup T, Johansen A, Madsbad S, Larsen S, Hansen T, Pedersen O, Holst JJ. J Clin Endocrinol Metab; 2003 Oct; 88(10):4897-903. PubMed ID: 14557471 [Abstract] [Full Text] [Related]
34. Islet hormonal regulation of glucose turnover during exercise in type 1 diabetes. Shilo S, Sotsky M, Shamoon H. J Clin Endocrinol Metab; 1990 Jan; 70(1):162-72. PubMed ID: 1967178 [Abstract] [Full Text] [Related]
35. Perfect normalization of excessive glucagon responses to intravenous arginine in human diabetes mellitus with the artificial beta-cell. Kawamori R, Shichiri M, Kikuchi M, Yamasaki Y, Abe H. Diabetes; 1980 Sep; 29(9):762-5. PubMed ID: 7002690 [Abstract] [Full Text] [Related]
36. Plasma growth hormone, insulin, and glucagon responses to arginine infusion in children and adolescents with idiopathic short stature, isolated growth hormone deficiency, panhypopituitarism, and anorexia nervosa. Sizonenko PC, Rabinovitch A, Schneider P, Paunier L, Wollheim CB, Zahnd G. Pediatr Res; 1975 Sep; 9(9):733-8. PubMed ID: 1105371 [Abstract] [Full Text] [Related]
37. Pathophysiology of beta cell failure after prolonged remission of insulin-dependent diabetes mellitus (IDDM). Drucker D, Zinman B. Diabetes Care; 1984 Sep; 7(1):83-7. PubMed ID: 6423354 [Abstract] [Full Text] [Related]
38. Abnormal glucose modulation of islet A- and B-cell responses to arginine in non-insulin-dependent diabetes mellitus. Dimitriadis GD, Pehling GB, Gerich JE. Diabetes; 1985 Jun; 34(6):541-7. PubMed ID: 3891467 [Abstract] [Full Text] [Related]
39. Immunocytochemical study of the endocrine pancreas in the rat during normal pregnancy and during experimental diabetic pregnancy. Van Assche FA, Gepts W, Aerts L. Diabetologia; 1980 Jun; 18(6):487-91. PubMed ID: 6106615 [Abstract] [Full Text] [Related]
40. Glucagon stimulation test: assessment of beta-cell function in gestational diabetes mellitus. Jacobs ML, Verhoog S, van der Linden WH, Huisman WM, Wallenburg HC, Weber RF. Eur J Obstet Gynecol Reprod Biol; 1994 Jul; 56(1):27-30. PubMed ID: 7982513 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]